Iosimenol
Alternative Names: IosminLatest Information Update: 31 Mar 2010
At a glance
- Originator Biophysica Inc; Interpharma Praha
- Developer Interpharma Praha
- Class Benzamides; Nonionic contrast media; Propanolamines
- Mechanism of Action Radiography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 26 Aug 2008 Interpharma Praha has been acquired by Otsuka Pharmaceutical
- 19 Jan 2004 Phase-II/III clinical trials in Undefined indication (diagnosis) in Czech Republic (unspecified route)